|
 
 |
| EDITOR'S PAGE |
|
| Year : 2022 | Volume
: 11
| Issue : 1 | Page : 1 |
|
Editor's Page January 2022
Ravi R Kasliwal
Editor-in-Chief, Journal of Clinical and Preventive Cardiology, Gurugram, Haryana, India
| Date of Web Publication | 21-Apr-2022 |
Correspondence Address:
MD, DM, FIMSA, MNAMS, FASE Ravi R Kasliwal
Adjunct Professor Cardiology (NBE), Chairman, Clinical and Preventive Cardiology, Medanta - The Medicity, Sector 38, Gurugram - 122 001, Haryana
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/2250-3528.343647
How to cite this article:
Kasliwal RR. Editor's Page January 2022. J Clin Prev Cardiol 2022;11:1 |
As the New Year dawns, there is generally a feeling that 2022 is going to herald an era without coronavirus disease 2019 (COVID-19). However, all the same rumblings of a new variant, although less deadly, are being heard distantly. Hopefully, this year we will surmount this and give our children and elderly folk, at least time to study, rejoice and get out of their homes and lead normal life.
The current issue that you have in your hand has some unique features. The original articles discuss some unique aspects of coronary artery disease and one of these articles also has a well-articulated editorial along with it.
The first original article is “Clinical Presentation, Treatment, and In-hospital Outcomes of ST-Segment Elevation Myocardial Infarction: A North East Indian Study” from the Department of Cardiology, NEIGRIHMS, Shillong and Department of Cardiology, Disham Hospital, Siliguri. The authors are Dr Chandra Kumar Das et al. This prospective, hospital based study consists of 100 consecutive patients of ST-segment elevation myocardial infarction (STEMI). The mean age of the patients was 56.81+ 12.25 years. The patients were city dwellers. They were either smokers or chewed tobacco or had hypertension, dyslipidemia and diabetes mellitus. The important point underscored in the study was late recognition of symptom onset and delay in seeking medical care. These two aspects are observed widely in our country. They deserve attention by us.
The second article titled “Effect of White Blood Cell Indices and Glycemia on in Hospital Prognosis of ST-segment Elevated Myocardial Infarction” comes from Aurangabad, written by Dr. Jadhav and colleagues. It talks about common metrics that can be utilized for risk stratifying acute myocardial infarction patients. Dr. Satyanarayana's editorial “Glucometrics, Haematometrics, and Clinical Metrics: Simple Indices, Scores and Models for Risk Stratification and Prognostication in Acute Coronary Syndromes” is also well rounded and emphasizes the use of these simple parameters in everyday use with gratifying results. Undoubtedly, more studies are required in the long run.
The third article “Incidence Predictors and Outcome Of Significant Atrioventricular Block in Acute Coronary Syndrome − A Study From Major Center in North Eastern India” authored by Dr. Dutta and colleagues from Assam highlights the incidence of atrioventricular block in the entire spectrum of North Eastern India. She reports much worse prognosis in such individuals, which makes these observations noteworthy.
The fourth article from Dr. Harsha and colleagues summarizes the clinical profile of the modern era patients of seropositive syphilis with coronary artery disease who did not demonstrate appreciable aorto-osteal stenosis or coronary aneurysm. The sample size (150) is quite robust and truly amazing.
The present issue also includes an interesting case report. The authors report a case of patent ductus arteriosus with hand anomalies − an unusual combination, and hence, a must read.
The Editor and staff wish all the readers a happy 2022, and hopefully, return to normalcy at the earliest.
|
Search Pubmed for